In peritoneal surface pathology, time is the determining factor. The PSOGI 2025 Manifesto is clear: early diagnosis can mean the difference between treatment with curative intent and palliative care. At Viamed, through IVOQA, we implement high-resolution protocols to ensure patients receive an accurate response without unjustified delays.
The Challenge of Time: Why is diagnosis often delayed?
The main problem with peritoneal malignancies is that they are “experts in camouflage.” Symptoms are often vague and common to many benign conditions, causing patients to spend months, or even years, searching for an explanation for their discomfort.
Current Challenges Identified in PSOGI 2025
The manifesto highlights the barriers that currently prevent effective detection:
- Confusion with Benign Processes: Abdominal pain, bloating, and changes in bowel habits are often mistakenly attributed to heavy digestion or food intolerances.
- Failures in the Diagnostic Chain: Delays in imaging tests (CT, MRI), errors in biopsy interpretation, and a lack of immediate referral to advanced surgical oncology units.
- Emergency Diagnoses: In too many cases, the disease is discovered during emergency surgery for another cause or when the tumor is already in a very advanced stage.
- Geographic Inequality: Access to an expert second opinion varies drastically by region—a gap we bridge at IVOQA by providing national access to our unit.
The IVOQA Response: Technology and Specialization
To meet the future expectations set out by the manifesto, at IVOQA we have optimized the diagnostic process:
- Expert Pathology and Radiology Review: A test alone is not enough; it requires interpretation by eyes expert in the peritoneum. We have radiologists specialized in detecting millimeter-sized tumor implants.
- Molecular and Genetic Profiling: We analyze the biology of the tumor. Knowing its “genetic ID” allows us to predict how it will behave and which treatment will be most effective.
- Standardized Diagnostic Pathways: We reduce bureaucracy so that, upon suspicion, the patient can access high-resolution tests (CT, MRI, and tumor markers) in record time.
“An accurate diagnosis is the first step toward recovery.”
At IVOQA and Viamed, we work to ensure no symptom is ignored and every patient receives a clear roadmap from day one.
Do you have doubts about your diagnosis or need a review of your tests? Contact Dr. Delia Cortés at IVOQA and access a team expert in cutting-edge oncological diagnosis.
